• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Digital Respiratory Devices Market

    ID: MRFR/HC/12099-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Digital Respiratory Devices Market Research Report: By Product (Smart Inhalers, Nebulizers, Sensors, Apps), By Indication (Asthma, COPD, Other Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By End Use (Hospitals, Homecare Settings, Other Settings) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Digital Respiratory Devices Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Digital Respiratory Devices Market Summary

    The US Digital Respiratory Devices market is projected to grow from 14.5 USD Billion in 2024 to 180 USD Billion by 2035.

    Key Market Trends & Highlights

    US Digital Respiratory Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 25.73% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 180 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 14.5 USD Billion, reflecting a robust starting point for future expansion.
    • Growing adoption of digital health technologies due to increasing prevalence of respiratory diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 14.5 (USD Billion)
    2035 Market Size 180 (USD Billion)
    CAGR (2025-2035) 25.73%

    Major Players

    AstraZeneca, Novartis, Drive DeVilbiss Healthcare, Fisher and Paykel Healthcare, Omron, Medtronic, Boehringer Ingelheim, Nuvaira, Masimo, Philips, HillRom, ResMed, NeuroMetrix, GSK, Honeywell

    US Digital Respiratory Devices Market Trends

    The US Digital Respiratory Devices Market is experiencing significant growth driven by an increasing prevalence of respiratory diseases, such as asthma and COPD, which are prevalent in many populations across the country. The aging population further contributes to this rise, as older adults tend to have higher instances of respiratory conditions.

    Another key driver is the advancement of technology, which has led to the development of more sophisticated digital respiratory devices that integrate features like real-time monitoring, data analytics, and connectivity to patient management systems. This shift towards more efficient and connected healthcare solutions has been essential in boosting patient outcomes and promoting adherence to treatment plans.

    There are numerous opportunities within the US market that are ripe for exploration. Telehealth integration presents a significant opportunity, allowing respiratory care providers to monitor patients remotely, especially in rural areas where access to healthcare can be limited. The growing demand for at-home care solutions also opens doors for innovative products that offer convenience and enhanced patient engagement.

    Recent trends indicate a surge in consumer acceptance of digital health technologies, driven in part by the COVID-19 pandemic. The pandemic has accelerated interest in home healthcare and digital monitoring tools, leading to a greater awareness and adoption of digital respiratory devices among both patients and healthcare professionals.

    Moreover, many companies are focusing on user-friendly designs and improved user experiences to meet the needs of patients of varying ages and technological comfort levels. As a result, the US Digital Respiratory Devices Market is swiftly evolving, laying a foundation for future growth and innovation within the field.

    US Digital Respiratory Devices Market Drivers

    Market Segment Insights

    Digital Respiratory Devices Market Product Insights

    The US Digital Respiratory Devices Market is characterized by a diverse range of products that cater to the growing demand for innovative solutions in respiratory health management. Within this market, key offerings such as smart inhalers, nebulizers, sensors, and mobile applications have emerged, reflecting a significant transformation in the management of respiratory conditions.

    Smart inhalers represent a valuable development in this sector, integrating advanced technology to track medication usage and provide real-time feedback to patients, thereby enhancing adherence to treatment protocols.Nebulizers continue to play a crucial role in delivering medication directly to the lungs, particularly for individuals with chronic respiratory conditions like asthma and COPD.

    The integration of sensors into nebulizers and inhalers aids in monitoring patient usage and medication effectiveness, paving the way for personalized treatment plans. Mobile applications further complement this by allowing users to log symptoms and medication schedules, track their health progress, and receive reminders, facilitating better patient engagement and communication with healthcare providers.

    The intersection of these products showcases how technological advancements are being leveraged to improve patient outcomes and drive the future of respiratory care in the US. With the increasing prevalence of respiratory diseases and the ongoing need to enhance patient care, the importance of these products within the US Digital Respiratory Devices Market is becoming increasingly evident, supporting a trend towards more connected and patient-centric approaches in the healthcare industry.

    As this market evolves, it presents a wealth of opportunities for growth, innovation, and enhanced patient experiences across various demographics and clinical settings.

    Digital Respiratory Devices Market Indication Insights

    The US Digital Respiratory Devices Market is significantly influenced by the Indication segment, which encompasses conditions like Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Other Diseases. Asthma represents a major health burden in the United States, affecting millions and highlighting the need for effective monitoring and management solutions.

    Digital respiratory devices designed for asthma patients facilitate real-time tracking of symptoms and medication adherence, enhancing patient outcomes. COPD also plays a vital role, being a leading cause of morbidity and mortality, and necessitating innovative approaches to disease management.

    Devices aimed at COPD patients help optimize treatment regimens and improve quality of life. Furthermore, the inclusion of Other Diseases illustrates the breadth of the market, catering to various respiratory conditions that require specialized digital solutions.

    Together, these indications are expected to shape the landscape of the US Digital Respiratory Devices Market by driving advancements in technology, such as telehealth and wearable devices, that ensure better disease management and patient engagement. The ongoing integration of digital solutions in respiratory care presents valuable opportunities for improved patient care and healthcare efficiency.

    Digital Respiratory Devices Market Distribution Channel Insights

    The Distribution Channel segment of the US Digital Respiratory Devices Market plays a vital role in ensuring accessibility and availability of these essential medical devices across various platforms. Hospital Pharmacies significantly contribute to the market by providing immediate access to respiratory devices for patients in critical care settings, ensuring that healthcare providers can swiftly respond to patient needs.

    Retail Pharmacies cater to a broader consumer base, allowing patients to conveniently obtain devices for home use, thus enhancing patient compliance and monitoring.Meanwhile, Online Pharmacies have emerged as a crucial player, particularly with the increase in telehealth services and online consultations, offering convenience and often competitive pricing.

    The ongoing digitalization in the healthcare sector in the US is also driving the growth of these distribution channels, as it aligns with the demand for more accessible healthcare solutions. Each channel brings unique strengths to the market, addressing consumer preferences for accessibility, urgency in medical care, and the evolving landscape of healthcare services.

    Therefore, the dynamics within the Distribution Channels not only reflect consumer behavior but also the industry's adaptability to changes in healthcare delivery models.

    Digital Respiratory Devices Market End Use Insights

    The US Digital Respiratory Devices Market exhibits a diverse range of applications, particularly within the End Use segment, which includes Hospitals, Homecare Settings, and Other Settings. Hospitals are crucial in this market, acting as primary centers for critical care and advanced respiratory support.

    The increasing prevalence of respiratory diseases and the demand for real-time monitoring contribute to the significance of this setting. Homecare Settings are also gaining traction, driven by a growing preference for at-home healthcare solutions that provide convenience and reduce healthcare costs.This segment's expansion reflects a broader trend toward personalized healthcare.

    Other Settings, including long-term care facilities, further complement the market by addressing unique respiratory care needs with specialized digital devices. The US Digital Respiratory Devices Market segmentation highlights these various end uses, indicating a robust growth potential fueled by technological advancements and evolving patient care models.

    The rising number of aging populations and the consistent push for improved patient outcomes present considerable opportunities, making each of these segments integral to the overall market landscape.

    Get more detailed insights about US Digital Respiratory Devices Market

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The US Digital Respiratory Devices Market is rapidly evolving, driven by advances in technology and increasing healthcare demands. This market encompasses a wide range of devices that utilize digital solutions to improve respiratory health management and offer real-time data for clinicians and patients alike.

    The competitive landscape features a mix of established pharmaceutical companies, innovative startups, and technology firms entering the healthcare space, all vying for market share with various strategies. Companies in this sector focus on enhancing user experience and compliance, leveraging data analytics, and integrating their devices with broader digital health ecosystems.

    As the market matures, firms are also facing the challenge of navigating regulatory frameworks and ensuring that their products meet user expectations while maintaining efficacy and safety.AstraZeneca has established a notable presence in the US Digital Respiratory Devices Market, leveraging its strong portfolio of respiratory medications to support device integration and patient adherence.

    The company recognizes the importance of digital transformation in healthcare and has invested in developing solutions that enhance patient outcomes, such as smart inhalers that provide feedback and connectivity to healthcare providers. AstraZeneca's commitment to innovative therapies, combined with its strong research and development capabilities, positions it as a leader in this sector.

    The company's partnership with technology firms allows for the seamless integration of digital solutions, enhancing the overall value proposition of its respiratory products.Novartis, on the other hand, is also a key player in the US Digital Respiratory Devices Market, focusing on the intersections between pharmacological and non-pharmacological approaches to respiratory care.

    The company invests heavily in developing advanced therapies alongside digital tools designed to empower patients and improve treatment adherence. Novartis has a strong range of respiratory products and is notable for its efforts in personalized medicine, which aims to tailor treatments based on individual patient needs.

    The company's expansions through strategic mergers and acquisitions enhance its market presence in the digital space, bringing innovative solutions to the forefront. With an ongoing commitment to research, Novartis not only strengthens its existing product offerings but also explores new avenues for improving patient care in the respiratory domain.

    Key Companies in the US Digital Respiratory Devices Market market include

    Industry Developments

    The US Digital Respiratory Devices Market has seen significant developments recently, particularly with the ongoing advancements in technology and rising demand for telehealth solutions. In June 2023, AstraZeneca announced the launch of an innovative digital platform aimed at improving asthma management, leveraging data analytics for personalized treatment.

    Meanwhile, in August 2023, Medtronic expanded its respiratory offerings with the introduction of a new remote monitoring system, enhancing patient care continuity. Notable mergers within this market include Novartis's acquisition of a digital health startup in July 2023, which aims to bolster its respiratory portfolio and digital solutions.

    The pandemic-driven shift towards home care solutions continues to influence growth, with companies like ResMed and Philips investing heavily in digital health technologies and software for remote patient monitoring. The market is projected to see continued expansion due to increased healthcare spending and the ongoing demand for innovative respiratory management solutions.

    Innovation, particularly in AI-powered devices, is further catalyzing market growth. Over the last few years, the regulatory environment has evolved, supporting swift approvals for digital health applications in respiratory care settings, contributing positively to the overall market landscape.

    Market Segmentation

    Digital Respiratory Devices Market End Use Outlook

    • Hospitals
    • Homecare Settings
    • Other Settings

    Digital Respiratory Devices Market Product Outlook

    • Smart Inhalers
    • Nebulizers
    • Sensors
    • Apps

    Digital Respiratory Devices Market Indication Outlook

    • Asthma
    • COPD
    • Other Diseases

    Digital Respiratory Devices Market Distribution Channel Outlook

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 11.22(USD Billion)
    MARKET SIZE 2024 14.5(USD Billion)
    MARKET SIZE 2035 180.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 25.732% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED AstraZeneca, Novartis, Drive DeVilbiss Healthcare, Fisher and Paykel Healthcare, Omron, Medtronic, Boehringer Ingelheim, Nuvaira, Masimo, Philips, HillRom, ResMed, NeuroMetrix, GSK, Honeywell
    SEGMENTS COVERED Product, Indication, Distribution Channel, End Use
    KEY MARKET OPPORTUNITIES Telehealth integration, Chronic disease management solutions, Home monitoring devices expansion, Artificial intelligence adoption, Personalized therapy advancements
    KEY MARKET DYNAMICS Increasing prevalence of respiratory diseases, Growing demand for telehealth solutions, Technological advancements in devices, Rising healthcare expenditure, Government support and funding
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected size of the US Digital Respiratory Devices Market in 2024?

    The US Digital Respiratory Devices Market is expected to reach a value of 14.5 billion USD in 2024.

    What will the market value of the US Digital Respiratory Devices Market be by 2035?

    By 2035, the US Digital Respiratory Devices Market is projected to be valued at 180.0 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Digital Respiratory Devices Market from 2025 to 2035?

    The market is expected to experience a CAGR of 25.732% from 2025 to 2035.

    Which product segment will dominate the US Digital Respiratory Devices Market by 2035?

    Smart inhalers will dominate the market with a projected value of 65.0 billion USD by 2035.

    What is the projected value of nebulizers in the US Digital Respiratory Devices Market by 2035?

    Nebulizers are expected to reach a value of 50.0 billion USD in the market by 2035.

    Who are the key players in the US Digital Respiratory Devices Market?

    Key players include AstraZeneca, Novartis, Medtronic, and Philips among others.

    What are the projected revenues for sensors in the market by 2035?

    The projected revenues for sensors in the US Digital Respiratory Devices Market will be 30.0 billion USD by 2035.

    How much will the apps segment generate in the US Digital Respiratory Devices Market by 2035?

    The apps segment is expected to generate revenue of 35.0 billion USD by 2035.

    What are some of the emerging trends in the US Digital Respiratory Devices Market?

    Emerging trends include the rise of smart inhalers and increased integration of digital health technologies.

    What challenges might the US Digital Respiratory Devices Market face in the coming years?

    Challenges may include regulatory hurdles and the need for continuous innovation to meet changing consumer demands.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Digital Respiratory Devices Market, BY Product (USD Billion)
    45. Smart Inhalers
    46. Nebulizers
    47. Sensors
    48. Apps
    49. US Digital Respiratory Devices Market, BY Indication (USD Billion)
    50. Asthma
    51. COPD
    52. Other Diseases
    53. US Digital Respiratory Devices Market, BY Distribution Channel (USD Billion)
    54. Hospital Pharmacies
    55. Retail Pharmacies
    56. Online Pharmacies
    57. US Digital Respiratory Devices Market, BY End Use (USD Billion)
    58. Hospitals
    59. Homecare Settings
    60. Other Settings
    61. Competitive Landscape
    62. Overview
    63. Competitive Analysis
    64. Market share Analysis
    65. Major Growth Strategy in the Digital Respiratory Devices Market
    66. Competitive Benchmarking
    67. Leading Players in Terms of Number of Developments in the Digital Respiratory Devices Market
    68. Key developments and growth strategies
    69. New Product Launch/Service Deployment
    70. Merger & Acquisitions
    71. Joint Ventures
    72. Major Players Financial Matrix
    73. Sales and Operating Income
    74. Major Players R&D Expenditure. 2023
    75. Company Profiles
    76. AstraZeneca
    77. Financial Overview
    78. Products Offered
    79. Key Developments
    80. SWOT Analysis
    81. Key Strategies
    82. Novartis
    83. Financial Overview
    84. Products Offered
    85. Key Developments
    86. SWOT Analysis
    87. Key Strategies
    88. Drive DeVilbiss Healthcare
    89. Financial Overview
    90. Products Offered
    91. Key Developments
    92. SWOT Analysis
    93. Key Strategies
    94. Fisher and Paykel Healthcare
    95. Financial Overview
    96. Products Offered
    97. Key Developments
    98. SWOT Analysis
    99. Key Strategies
    100. Omron
    101. Financial Overview
    102. Products Offered
    103. Key Developments
    104. SWOT Analysis
    105. Key Strategies
    106. Medtronic
    107. Financial Overview
    108. Products Offered
    109. Key Developments
    110. SWOT Analysis
    111. Key Strategies
    112. Boehringer Ingelheim
    113. Financial Overview
    114. Products Offered
    115. Key Developments
    116. SWOT Analysis
    117. Key Strategies
    118. Nuvaira
    119. Financial Overview
    120. Products Offered
    121. Key Developments
    122. SWOT Analysis
    123. Key Strategies
    124. Masimo
    125. Financial Overview
    126. Products Offered
    127. Key Developments
    128. SWOT Analysis
    129. Key Strategies
    130. Philips
    131. Financial Overview
    132. Products Offered
    133. Key Developments
    134. SWOT Analysis
    135. Key Strategies
    136. HillRom
    137. Financial Overview
    138. Products Offered
    139. Key Developments
    140. SWOT Analysis
    141. Key Strategies
    142. ResMed
    143. Financial Overview
    144. Products Offered
    145. Key Developments
    146. SWOT Analysis
    147. Key Strategies
    148. NeuroMetrix
    149. Financial Overview
    150. Products Offered
    151. Key Developments
    152. SWOT Analysis
    153. Key Strategies
    154. GSK
    155. Financial Overview
    156. Products Offered
    157. Key Developments
    158. SWOT Analysis
    159. Key Strategies
    160. Honeywell
    161. Financial Overview
    162. Products Offered
    163. Key Developments
    164. SWOT Analysis
    165. Key Strategies
    166. References
    167. Related Reports
    168. US Digital Respiratory Devices Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    169. US Digital Respiratory Devices Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)
    170. US Digital Respiratory Devices Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)
    171. US Digital Respiratory Devices Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)
    172. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    173. ACQUISITION/PARTNERSHIP
    174. MARKET SYNOPSIS
    175. US DIGITAL RESPIRATORY DEVICES MARKET ANALYSIS BY PRODUCT
    176. US DIGITAL RESPIRATORY DEVICES MARKET ANALYSIS BY INDICATION
    177. US DIGITAL RESPIRATORY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    178. US DIGITAL RESPIRATORY DEVICES MARKET ANALYSIS BY END USE
    179. KEY BUYING CRITERIA OF DIGITAL RESPIRATORY DEVICES MARKET
    180. RESEARCH PROCESS OF MRFR
    181. DRO ANALYSIS OF DIGITAL RESPIRATORY DEVICES MARKET
    182. DRIVERS IMPACT ANALYSIS: DIGITAL RESPIRATORY DEVICES MARKET
    183. RESTRAINTS IMPACT ANALYSIS: DIGITAL RESPIRATORY DEVICES MARKET
    184. SUPPLY / VALUE CHAIN: DIGITAL RESPIRATORY DEVICES MARKET
    185. DIGITAL RESPIRATORY DEVICES MARKET, BY PRODUCT, 2025 (% SHARE)
    186. DIGITAL RESPIRATORY DEVICES MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    187. DIGITAL RESPIRATORY DEVICES MARKET, BY INDICATION, 2025 (% SHARE)
    188. DIGITAL RESPIRATORY DEVICES MARKET, BY INDICATION, 2019 TO 2035 (USD Billions)
    189. DIGITAL RESPIRATORY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE)
    190. DIGITAL RESPIRATORY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
    191. DIGITAL RESPIRATORY DEVICES MARKET, BY END USE, 2025 (% SHARE)
    192. DIGITAL RESPIRATORY DEVICES MARKET, BY END USE, 2019 TO 2035 (USD Billions)
    193. BENCHMARKING OF MAJOR COMPETITORS

    US Digital Respiratory Devices Market Segmentation

     

     

     

    • Digital Respiratory Devices Market By Product (USD Billion, 2019-2035)

      • Smart Inhalers
      • Nebulizers
      • Sensors
      • Apps

     

    • Digital Respiratory Devices Market By Indication (USD Billion, 2019-2035)

      • Asthma
      • COPD
      • Other Diseases

     

    • Digital Respiratory Devices Market By Distribution Channel (USD Billion, 2019-2035)

      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies

     

    • Digital Respiratory Devices Market By End Use (USD Billion, 2019-2035)

      • Hospitals
      • Homecare Settings
      • Other Settings

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027